* AVITA Medical Inc RCEL.OQ reported a quarterly adjusted
loss
of 41 cents per share for the quarter ended in June. The mean
expectation of five analysts for the quarter was for a loss
of 32 cents per share.
* Revenue rose 41% to $11.75 million from a year ago;
analysts
expected $11.32 million.
* AVITA Medical Inc's reported EPS for the quarter was a
loss
of 41 cents.
* The mean earnings estimate of analysts had fallen by
about 11.7%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* AVITA Medical Inc shares had risen by 5.8% this
quarter and
gained 172.7% so far this year.
* The company reported a quarterly loss of $10.38 million.
* Wall Street's median 12-month price target for AVITA
Medical Inc
is $24.50
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
August 10 at 10:32 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 -0.32 -0.41 Missed
Mar. 31 2023 -0.25 -0.37 Missed
Dec. 31 2022 -0.29 -0.22 Beat
Sep. 30 2022 -0.34 -0.22 Beat